This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Veterans Advancing ALS/MND Wins Sanofi US Innovation Challenge: Collaborate Innovate

BRIDGEWATER, N.J., May 12, 2014 /PRNewswire/ -- Sanofi US announced the winner of its second Innovation Challenge: Collaborate Innovate. The winner, Veterans Advancing ALS/MND , is a partnership that comprises Innovative Solutions Consortium and Johns Hopkins University.  In the spirit of collaboration, Sanofi's Partners in Patient Health and North America Research & Development Hub coordinated the Collaborate Innovate Challenge to strengthen the patient voice in the drug development process. Independent judges selected the winning team from four finalists selected to present their concepts to a live audience at an event at the Sanofi US Bridgewater campus.

Veterans Advancing ALS/MND Team Wins Sanofi's Partners in Patient Health and North America Research & Development Hub Collaborate Innovate Challenge

Veterans Advancing ALS/MND will conduct data analysis to provide new clues to the higher incidence of ALS in veterans. ALS (Amyotrophic Lateral Sclerosis/Motor Neuron Disease, aka ALS, or " Lou Gehrig's Disease") is a neurodegenerative disease with no substantial therapies. The concept will connect open innovation, reliable veterans' organizations and the ALS research community to provide new conclusive insights about ALS and accelerate application of individualized therapies.

"Winning this challenge provides Veterans Advancing ALS/MND with urgently needed resources to help ALS/MND veterans receive better care, as well as develop new therapies tailored to individual patient needs," said Steve Hunt, Executive Director, Innovative Solutions Consortium. "Our approach will demonstrate advances in individualized treatments for many diseases, not just ALS/MND."

For the past two months, each of the four finalist teams received mentorship from Sanofi team members and functional experts in business strategy, marketing and communications, systems thinking, decision sciences, and healthcare venture capital, drawing on cooperative insights to refine their solution before presenting to the judges.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,912.11 -70.48 -0.42%
S&P 500 1,969.95 -8.96 -0.45%
NASDAQ 4,442.6980 -2.2110 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs